Changes in 5-
in particular has been implicated in affective disorders such as anxiety and depression. Adaptive changes in the serotonergic system are believed to underlie the therapeutic effectiveness of the azapirone anxiolytics and a variety of antidepressant drugs. Thus, studies of the regulation of 5-HT 1A receptor function may have important implications for our understanding the role of this receptor in the mechanism of action of these therapeutic agents.
Chronic administration of selective serotonin reuptake inhibitors (SSRIs) results in the desensitization of 5-HT 1A somatodendritic autoreceptor function in the dorsal raphe (see Blier and de Montigny 1994; Kreiss and Lucki 1995; Le Poul et al. 2000) . Chronic SSRI treatment also results in the desensitization of physiological responses mediated by postsynaptic 5-HT 1A receptors (Goodwin et al. 1987; Hensler et al. 1991; Li et al. 1996) . Electrophysiological and neurochemical studies indicate, however, that in hippocampus the sensitivity of postsynaptic 5-HT 1A receptor-mediated responses is not changed (Blier and de Montigny 1983; Chaput et al. 1986; Varrault et al. 1991; Le Poul et al. 2000) .
Unlike the SSRIs, chronic administration of tricyclic antidepressants does not result in the desensitization of the 5-HT 1A somatodendritic autoreceptor (Blier and de Montigny 1980; Kreiss and Lucki 1995) . Although some investigators have reported an attenuation of behavioral and physiological responses mediated by postsynaptic 5-HT 1A receptors (Goodwin et al. 1987; Lesch et al. 1990 ), this has not been a consistent observation (Lucki and Frazer 1982; Wozniak et al. 1987; Hensler et al. 1991; Gartside et al. 1992) . Electrophysiological studies indicate that chronic treatment with tricyclic antidepressants results in the sensitization of postsynaptic neurons in hippocampus to 5-HT 1A receptor agonists (de Montigny and Aghajanian 1978; Chaput et al. 1991) .
These discrepant observations regarding the regulation of postsynaptic 5-HT 1A receptor sensitivity following chronic SSRI or tricyclic antidepressant administration may be due to the effects of these drug treatments on complex neuronal circuits, or differences in the regulation of 5-HT 1A receptor function in specific brain regions. In general, changes in 5-HT 1A receptor number have not been observed following chronic administration of antidepressants (Wieland et al. 1993; Hensler et al. 1991; Le Poul et al. 2000; Hervàs et al. 2001) . Because changes in the sensitivity of 5-HT 1A receptor-mediated responses do not appear to be mediated by changes in 5-HT 1A receptor binding, the basis for changes in 5-HT 1A receptor function or sensitivity may involve changes in the capacity of the 5-HT 1A receptor to activate G protein. Receptor-stimulated [ ]GTP ␥ S autoradiography allows the demonstration of receptor-G protein interaction with neuroanatomical resolution. We have used this approach previously to examine regional differences in the regulation of the 5-HT 1A receptor at the level of receptor-G protein interaction following chronic agonist administration (Hensler and Durgam 2001) .
In the current study we have examined the effect of repeated administration of the SSRI fluoxetine or the tricyclic antidepressant amitriptyline on 5-HT 1A receptor-stimulated [ 35 S]GTP ␥ S binding. Using quantitative autoradiography, this analysis was performed for postsynaptic 5-HT 1A receptors in forebrain areas, which serve as terminal field areas of serotonergic innervation, and presynaptic 5-HT 1A receptors located on the soma and dendrites of serotonergic cell bodies in the dorsal and median raphe nuclei. The present study is the first to report the use of [ 35 S]GTP ␥ S autoradiography to study the regulation of 5-HT 1A receptor-G protein interaction in brain following repeated antidepressant administration.
METHODS

Animals
Male Sprague-Dawley rats (250-300 g; Harlan, Indianapolis, IN) were group-housed and maintained on a 14:10 h day:night cycle with constant access to food and water. These studies were carried out in accordance with the Guide for the Care and Use of Laboratory Animals as adopted and promulgated by the National Institutes of Health.
Drug Treatment
Rats were injected intraperitoneally (i.p.) with saline ( n ϭ 12), fluoxetine (10 mg/kg) (n ϭ 8), or amitriptyline (10 mg/kg) ( n ϭ 8) once a day for 14 days. Amitriptyline ( ϭ 1 ml/kg) and fluoxetine ( ϭ 2 ml/kg) were dissolved in water and injected according to body weight. These doses of amitriptyline and fluoxetine were chosen from the literature to correspond to clinically relevant doses (de Montigny and Aghajanian 1978; Czachura and Rasmussen 2000) . Fresh fluoxetine and amitriptyline solutions were made each day. Animals were injected at the same time each day, specifically between 11:00 A . M . and 1:00 P . M . Animals were sacrificed 48 h after the last injection.
Tissue Preparation
Rat brains were rapidly removed and frozen on powdered dry ice. Brains were stored at -80 Њ C until sectioning. Coronal sections of 20 m thickness were cut at Ϫ 17 Њ C in a cryostat microtome at the level of the lateral septum, dorsal hippocampus or dorsal raphe according to the atlas of the rat brain of Paxinos and Watson (1986) . Sections were thaw-mounted onto gelatincoated glass slides, desiccated at 4 Њ C for 18 h under vacuum and then stored at Ϫ 80 Њ C until use. S]GTP ␥ S binding above basal were obtained with 2 mM GDP and 3 mM MgCl 2 in the assay buffer. Slide-mounted sections were thawed and desiccated at 4 Њ C for 2 h, and then equilibrated in HEPES buffer (50 mM, pH 7.4), supplemented with 3 mM MgCl 2 , 0.2 mM EGTA, 100 mM NaCl, and 0.2 mM dithiothreitol for 10 min at 30 Њ C. Sections were pre-incubated in HEPES buffer containing GDP (2 mM) for 10 min at 30 Њ C, and then incubated in HEPES buffer containing GDP (2 mM) and 80 pM [ ]GTP␥S binding was defined in the absence of (Ϯ)8-OH-DPAT and in the presence of 10 M GTP␥S. The incubation was stopped by two washes for 2 min each in ice-cold 50 mM Tris-HCl buffer (pH 7.4), followed by a brief immersion in icecold de-ionized water. Sections were dried on a slidewarmer and exposed to Kodak Biomax MR film (Amersham) for 24 h. receptors in brain sections was performed as described (Clarke et al. 2001; Hensler and Durgam 2001) . Briefly, slide-mounted sections were thawed and desiccated at 4ЊC for 2 h. Sections were pre-incubated for 30 min at 30ЊC in assay buffer (170 mM Tris-HCl, pH 7.6), and then incubated in assay buffer containing 10 nM 
Image Analysis
Analysis of the digitized autoradiograms was performed using the image analysis program NIH Image, version 1.47 (NIH, Bethesda, MD). Tissue sections were stained with thionin and the brain areas identified using the atlas of the rat brain of Paxinos and Watson (1986) Louis, MO) which had been calibrated using brainmash sections according to the method of Geary and Wooten (Geary and Wooten 1983; Geary et al. 1985) . The amount of ligand bound was determined by converting optical density measurements to femtomoles per milligram of protein. 
Data Analysis
Statistical comparisons were made by ANOVA. F values reaching significance (p Ͻ .05) were evaluated further by post hoc analysis using Fisher's Protected Least Significant Difference test. Statistical tests were performed using Statistica software (version 4.1, Statsoft, Tulsa, OK). 
Materials
RESULTS
In confirmation of earlier studies (Waeber and Moskowitz 1997; Sim et al. 1997; Meller et al. 2000; Hensler and Durgam 2001) , application of the 5-HT 1A receptor agonist (Ϯ)8-OH-DPAT (1 M) resulted in an increase in the binding of [ 
S]GTP␥S was stimulated by (Ϯ)8-OH-DPAT (1 M).
cortical areas examined following chronic amitriptyline administration (Table 1 ). An increase in 5-HT 1A receptor number in hippocampus following chronic amitriptyline treatment, in the absence of an increase in (Ϯ)8-OH-DPAT-stimulated [ 
DISCUSSION
In the current study we have examined the effect of chronic administration of the SSRI fluoxetine or the tricyclic antidepressant amitriptyline on 5-HT 1A receptorstimulated [ ]GTP␥S binding was observed in any of the forebrain areas examined following chronic treatment with either antidepressant. Thus changes in postsynaptic 5-HT 1A receptor-mediated responses reported to follow chronic SSRI or tricyclic antidepressant administration appear to occur more distal to receptor-G protein interaction, perhaps at the level of effector, or involving changes in neuronal function at the system or circuit level.
Desensitization of 5-HT 1A somatodendritic autoreceptor function in the dorsal raphe has been demonstrated in electrophysiological studies to follow chronic administration of the SSRI fluoxetine (Czachura and Rasmussen 2000; Le Poul et al. 2000) . In vivo microdialysis studies have confirmed these observations (Kreiss and Lucki 1995) . Chronic inactivation of 5-HT reuptake, by injection of antisense coding sequence of the 5-HT transporter gene into the dorsal raphe of the rat, results in a decrease in 5-HT 1A receptor-stimulated [ 35 S]GTP␥S binding in this brain region (Fabre et al. 2000b ). Similar observations have been made in knock-out mice lacking the 5-HT transporter, although in these mice 5-HT 1A receptor density in the dorsal raphe is significantly reduced (Fabre et al. 2000a ). In the current study, (Ϯ)8-OH-DPAT-stimulated [ Using the agonist radioligand [ 3 H]8-OH-DPAT, at a concentration near the Kd value, we and others have observed no change in 5-HT 1A receptor binding sites in the dorsal raphe following chronic SSRI administration (Hensler et al. 1991; Hervàs et al. 2001 (Hensler et al. 1991; Hervàs et al. 2001) suggests that the number of 5-HT 1A receptor sites in the coupled, high affinity state is not altered by this drug treatment. By measuring 8-OH-DPAT-stimulated [ 35 S]GTP␥S binding in the current study, we are measuring the ability of the agonist 8-OH-DPAT to stimulate the exchange of GTP␥S for GDP. Thus, this is a direct assay of receptor activation of G protein as a result of agonist binding. With chronic SSRI administration the number of receptors in the coupled, high affinity state is unchanged (Hensler et al. 1991; Hervàs et al. 2001) , but the ability of agonist to stimulate the exchange of GTP␥S for GDP is decreased, an indication that the activation of G protein by the receptor as a result of agonist binding is reduced. A reduced capacity of the 5-HT 1A receptor to activate G protein may be due to regulatory processes (e.g. phosphorylation) at the level of the G protein (see Lohse 1993) .
Unlike the SSRIs, chronic administration of tricyclic antidepressants (i.e. desipramine, imipramine and iprindole) does not result in the desensitization of the 5-HT 1A somatodendritic autoreceptor (Blier and de Montigny 1980; Kreiss and Lucki 1995) . Our findings in the current study are consistent with this, in that we observed no change in (Ϯ)8-OH-DPAT-stimulated [ 35 S]GTP␥S binding in the dorsal and median raphe nuclei following chronic administration of amitriptyline. Thus, following chronic amitriptyline treatment 5-HT 1A receptor-G protein interaction in the dorsal and median raphe appears to be unaltered.
Although some investigators have reported an attenuation of neuroendocrine or temperature responses mediated by postsynaptic 5-HT 1A receptors following chronic amitriptyline administration (Goodwin et al. 1987; Lesch et al. 1990 ), this has not been a consistent observation (Gartside et al. 1992; Yamada et al. 1994 ). Neuroendocrine and temperature responses mediated by postsynaptic 5-HT 1A receptors are also attenuated following chronic administration of fluoxetine (Li et al. 1996; Lerer et al. 1999) or a variety of SSRIs (see Introduction). However, we are unable to examine the regulation of 5-HT 1A receptor-G protein interaction in hypothalamus following chronic administration of antidepressant drugs due to the high level of basal [ (Hensler and Durgam, unpublished observations) .
As has been observed for a variety of SSRIs (see Introduction), chronic treatment with fluoxetine does not alter 5-HT 1A receptor-evoked electrophysiological responses in hippocampus (Le Poul et al. 2000) . Chronic inactivation of 5-HT reuptake, by injection of antisense coding sequence of the 5-HT transporter gene into the Our data suggest that following chronic fluoxetine treatment, the capacity of the 5-HT 1A receptor to activate G protein in the hippocampus is unaltered. Thus, changes in hippocampal 5-HT 1A receptor-mediated inhibition of adenylyl cyclase activity observed following chronic fluoxetine treatment (Newman et al. 1992 ) may be the result of changes at the level of effector (i.e. adenylyl cyclase).
Postsynaptic 5-HT 1A receptors may also play a role in the regulation of serotonergic neuronal firing rate and serotonin release through neuronal feedback loops between projection areas and raphe nuclei. Postsynaptic 5-HT 1A receptor-mediated feedback has been demonstrated in several terminal field areas of serotonergic innervation, including cortex (Ceci et al. 1994; Casanovas et al. 1999 ) and amygdala (Bosker et al. 1997) . Bosker et al. (2001) Electrophysiological studies indicate that chronic treatment with amitriptyline results in the sensitization of postsynaptic neurons to serotonin in the hippocampus, where this response has been shown to be mediated by the 5-HT 1A receptor (de Montigny and Aghajanian 1978; Gallager and Bunney 1978; Chaput et al. 1991 ). In the current study, however, we did not observe an increase in 5-HT 1A receptor-stimulated [ eas examined. Our data suggest that changes in the capacity of the 5-HT 1A receptor to activate G protein do not underlie this sensitization observed following chronic amitriptyline treatment. The sensitization of 5-HT 1A receptor-mediated electrophysiological responses in hippocampus may be due to changes in channel function. We did observe an increase in the number of 5-HT 1A receptor binding sites in hippocampus following chronic amitriptyline treatment, in confirmation of previous studies (Welner et al. 1989 ). However, because we did not observe a concomitant increase in 5-HT 1A receptor-stimulated [ 5-HT 1A receptors are coupled to the Gi family of G proteins, which include G i1 , G i2 , G i3 , G o and G z (Raymond et al. 1993; Barr et al. 1997) . Chronic administration of tricyclic antidepressants and the monoamine oxidase inhibitor clorgyline has been reported to decrease Gi␣ in several brain regions, while Go␣ was increased by tricyclic antidepressants but not clorgyline (Lesch et al. 1991) . Chronic administration of the SSRI fluoxetine produces a gradual reduction in the levels of G i1 , G i3 and G z protein in hypothalamus that matches the time course of desensitization of hypothalamic 5-HT 1A receptors (Li et al. 1996; Raap et al. 1999 ). Thus, fluoxetineinduced desensitization of hypothalamic postsynaptic 5-HT 1A receptor systems may be caused in part by reductions in Gz, which mediates hypothalamic 5-HT 1A receptor-stimulated ACTH and oxytocin secretion (Serres et al. 2000) . Thus, antidepressant efficacy and the regulation of 5-HT 1A receptor function may be based on compensatory changes distal to the receptor, such as regulation of G protein expression or as discussed above reduced capacity of the receptor to activate G protein due to regulatory processes (e.g. phosphorylation) at the level of the G protein.
